Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could pregnant women safely stop aspirin earlier? new trial investigates

NCT ID NCT06108947

Recruiting now Prevention Sponsor: St. Olavs Hospital Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This trial looks at whether pregnant women at high risk for preeclampsia can safely stop taking daily aspirin at 24-28 weeks instead of continuing until 36 weeks. Around 300 women will be randomly assigned to either stop or continue aspirin. The goal is to see if stopping early leads to the same low rate of preterm preeclampsia, potentially reducing medication burden.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
aspirin (acetyl salicylic acid)
What this could lead to
If stopping aspirin early is safe, it could simplify care for many pregnant women at risk of preeclampsia, reducing unnecessary medication.
What could go wrong
This is a small, open-label trial, so results may not apply broadly. Stopping aspirin could increase preeclampsia risk in some women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRE-ECLAMPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRE-ECLAMPSIA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • St. Olavs hospital

    RECRUITING

    Trondheim, Norway

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.